Head-to-head · WeighScore
PlexusDx vs Revel RX
By GLP-1 ScorecardUpdated
Score comparison
Revel RX has the higher recorded score — 77.3/100 to 67.7/100.
Revel RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Revel Rx advertises the same monthly price across doses and no separate membership fee. Its refund policy still refers to canceling a subscription.
Before you choose
Before comparing the headline prices, the PlexusDx review and the Revel RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, PlexusDx vs RxPros and Potere Health MD vs Revel RX compare each of them with another graded program, and the list of alternatives to PlexusDx ranks the programs closest to PlexusDx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | PlexusDx | Revel RX |
|---|---|---|
| WeighScore | 67.7/100 | 77.3/100 |
| Grade | C | C+ |
| Site position | #112 | #48 |
| Semaglutide | $99/mo (12-month plan; compounded) | $89/mo (advertised all doses, compounded) |
| Tirzepatide | $129/mo (12-month plan; compounded) | $155/mo (advertised all doses, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Licensed providers available in all 50 states
- Range of options including microdose GLP-1 from $69/mo on a 12-month plan
- Optional Precision Peptide genetic panel adds a personalization angle
- Independent clinician review via state-licensed telehealth platform
- Compounded medications from state-licensed pharmacies
What to consider
- Compounded medications only; no FDA-approved brand options
- Specific compounding pharmacies not named
- Genetic-panel upsell may not add clinical value for everyone
- The advertised $99 semaglutide and $129 tirzepatide rates require a 12-month plan; shorter-term prices were not visible
- No insurance accepted
Strengths
- Publishes prices for both compounded medications
- Advertises clinician review and included shipping
- Provides written instructions for canceling before shipment
What to consider
- The refund policy treats charged orders already handed to the carrier as final
- No dispensing pharmacy assignment or state eligibility was verified for an individual order
Featured provider
PlexusDx
Factor scores not reassessed.PlexusDx scores 67.7/100 (C). PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.